1
|
Bahl A, Alsbrooks K, Zazyczny KA, Johnson S, Hoerauf K. An Improved Definition and SAFE Rule for Predicting Difficult Intravascular Access (DIVA) in Hospitalized Adults. JOURNAL OF INFUSION NURSING 2024; 47:96-107. [PMID: 38377305 PMCID: PMC10913859 DOI: 10.1097/nan.0000000000000535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2024]
Abstract
Patients with difficult intravascular access (DIVA) are common, yet the condition is often ignored or poorly managed, leading to patient dissatisfaction and misuse of health care resources. This study sought to assess all published risk factors associated with DIVA in order to promote prospective identification and improved management of patients with DIVA. A systematic literature review on risk factors associated with DIVA was conducted. Risk factors published in ≥4 eligible studies underwent a multivariate meta-analysis of multiple factors (MVMA-MF) using the Bayesian framework. Of 2535 unique publications identified, 20 studies were eligible for review. In total, 82 unique DIVA risk factors were identified, with the 10 factors found in ≥4 studies undergoing MVMA-MF. Significant predictors of DIVA included vein visibility, vein palpability, history of DIVA, obesity (body mass index [BMI] >30), and history of intravenous (IV) drug abuse, which were combined to create the mnemonic guideline, SAFE: See, Ask (about a history of DIVA or IV drug abuse), Feel, and Evaluate BMI. By recognizing patients with DIVA before the first insertion attempt and treating them from the outset with advanced vein visualization techniques, patients with DIVA could be subject to less frequent painful venipunctures, fewer delays in treatment, and a reduction in other DIVA-associated burdens.
Collapse
Affiliation(s)
- Amit Bahl
- Emergency Medicine, Beaumont Hospital, Royal Oak, Michigan (Bahl and Johnson), Becton Dickinson and Co, Franklin Lakes, New Jersey (Alsbrooks and Hoerauf), and Bryn Mawr Hospital, Bryn Mawr, Pennsylvania (Zazyczny)
- Amit Bahl, MD, is a physician scientist with board certification in emergency medicine and subspeciality expertise in point-of-care ultrasound. He is the recipient of several foundation and industry grants for research and has authored numerous peer-reviewed manuscripts in high-impact medical journals. Dr Bahl is a passionate speaker who presents internationally on the complications of vascular access devices and strategies to improve patient outcomes
- Kim Alsbrooks has over 30 years of experience in the medical field. She started as a Radiologic Technologist then Registered Nurse, working on specialized hospital teams in Oncology and Vascular Access. She has worked at BARD/Becton, Dickinson, and Company, where she is now the Sr Director of Medical Affairs, for the past 20 years. Her work is mostly focused on vascular access evidence generation and research. Kim speaks across the US and internationally on vascular access topics
- Kelly Ann Zazyczny, BSN, RN, RT (R), VA-BC, is the director of nursing of the Psychiatric, Women, and Children's Division at Bryn Mawr Hospital, Vascular Access Nursing Services for the Main Line Health System. She has been a clinical leader for over 25 years, holding positions at Main Line Health, The Children's Hospital of Philadelphia, and Children's Healthcare of Atlanta. Her clinical focus has been on pediatrics, vascular access, radiology, and research. She has been named one of the Top Nurses in Nursing Management by Main Line Today for the last 3 years
- Steven Johnson, DO, is a board-certified emergency medicine physician and critical care fellow at the University of Southern California. He also conducts catheter-related research in his work as a research scientist at Beaumont Health. He developed a passion for improving peripheral venous access after witnessing firsthand how poor catheter performance affects patient outcomes and overall health
- Klaus Hoerauf, MD, PhD, currently serves as worldwide vice president of medical affairs, medication delivery solutions, at Becton, Dickinson, and Company. In this role, he leads Medical & Scientific Affairs and Health Economics and Outcomes Research departments. He has an MD and a Doctorate in Cardiology from the Medical University of Münster and has been appointed as associate professor of anesthesiology and intensive care medicine at the Medical University of Vienna, Austria. He is certified in anesthesiology and intensive care medicine, emergency medicine, and pain therapy
| | - Kimberly Alsbrooks
- Corresponding Author: Kimberly Alsbrooks, BSN, RN, RT (R), VA-BC, Becton Dickinson and Company, 18-03 NJ-208, Franklin Lakes, NJ, USA 07417 ()
| | - Kelly Ann Zazyczny
- Emergency Medicine, Beaumont Hospital, Royal Oak, Michigan (Bahl and Johnson), Becton Dickinson and Co, Franklin Lakes, New Jersey (Alsbrooks and Hoerauf), and Bryn Mawr Hospital, Bryn Mawr, Pennsylvania (Zazyczny)
- Amit Bahl, MD, is a physician scientist with board certification in emergency medicine and subspeciality expertise in point-of-care ultrasound. He is the recipient of several foundation and industry grants for research and has authored numerous peer-reviewed manuscripts in high-impact medical journals. Dr Bahl is a passionate speaker who presents internationally on the complications of vascular access devices and strategies to improve patient outcomes
- Kim Alsbrooks has over 30 years of experience in the medical field. She started as a Radiologic Technologist then Registered Nurse, working on specialized hospital teams in Oncology and Vascular Access. She has worked at BARD/Becton, Dickinson, and Company, where she is now the Sr Director of Medical Affairs, for the past 20 years. Her work is mostly focused on vascular access evidence generation and research. Kim speaks across the US and internationally on vascular access topics
- Kelly Ann Zazyczny, BSN, RN, RT (R), VA-BC, is the director of nursing of the Psychiatric, Women, and Children's Division at Bryn Mawr Hospital, Vascular Access Nursing Services for the Main Line Health System. She has been a clinical leader for over 25 years, holding positions at Main Line Health, The Children's Hospital of Philadelphia, and Children's Healthcare of Atlanta. Her clinical focus has been on pediatrics, vascular access, radiology, and research. She has been named one of the Top Nurses in Nursing Management by Main Line Today for the last 3 years
- Steven Johnson, DO, is a board-certified emergency medicine physician and critical care fellow at the University of Southern California. He also conducts catheter-related research in his work as a research scientist at Beaumont Health. He developed a passion for improving peripheral venous access after witnessing firsthand how poor catheter performance affects patient outcomes and overall health
- Klaus Hoerauf, MD, PhD, currently serves as worldwide vice president of medical affairs, medication delivery solutions, at Becton, Dickinson, and Company. In this role, he leads Medical & Scientific Affairs and Health Economics and Outcomes Research departments. He has an MD and a Doctorate in Cardiology from the Medical University of Münster and has been appointed as associate professor of anesthesiology and intensive care medicine at the Medical University of Vienna, Austria. He is certified in anesthesiology and intensive care medicine, emergency medicine, and pain therapy
| | - Steven Johnson
- Emergency Medicine, Beaumont Hospital, Royal Oak, Michigan (Bahl and Johnson), Becton Dickinson and Co, Franklin Lakes, New Jersey (Alsbrooks and Hoerauf), and Bryn Mawr Hospital, Bryn Mawr, Pennsylvania (Zazyczny)
- Amit Bahl, MD, is a physician scientist with board certification in emergency medicine and subspeciality expertise in point-of-care ultrasound. He is the recipient of several foundation and industry grants for research and has authored numerous peer-reviewed manuscripts in high-impact medical journals. Dr Bahl is a passionate speaker who presents internationally on the complications of vascular access devices and strategies to improve patient outcomes
- Kim Alsbrooks has over 30 years of experience in the medical field. She started as a Radiologic Technologist then Registered Nurse, working on specialized hospital teams in Oncology and Vascular Access. She has worked at BARD/Becton, Dickinson, and Company, where she is now the Sr Director of Medical Affairs, for the past 20 years. Her work is mostly focused on vascular access evidence generation and research. Kim speaks across the US and internationally on vascular access topics
- Kelly Ann Zazyczny, BSN, RN, RT (R), VA-BC, is the director of nursing of the Psychiatric, Women, and Children's Division at Bryn Mawr Hospital, Vascular Access Nursing Services for the Main Line Health System. She has been a clinical leader for over 25 years, holding positions at Main Line Health, The Children's Hospital of Philadelphia, and Children's Healthcare of Atlanta. Her clinical focus has been on pediatrics, vascular access, radiology, and research. She has been named one of the Top Nurses in Nursing Management by Main Line Today for the last 3 years
- Steven Johnson, DO, is a board-certified emergency medicine physician and critical care fellow at the University of Southern California. He also conducts catheter-related research in his work as a research scientist at Beaumont Health. He developed a passion for improving peripheral venous access after witnessing firsthand how poor catheter performance affects patient outcomes and overall health
- Klaus Hoerauf, MD, PhD, currently serves as worldwide vice president of medical affairs, medication delivery solutions, at Becton, Dickinson, and Company. In this role, he leads Medical & Scientific Affairs and Health Economics and Outcomes Research departments. He has an MD and a Doctorate in Cardiology from the Medical University of Münster and has been appointed as associate professor of anesthesiology and intensive care medicine at the Medical University of Vienna, Austria. He is certified in anesthesiology and intensive care medicine, emergency medicine, and pain therapy
| | - Klaus Hoerauf
- Emergency Medicine, Beaumont Hospital, Royal Oak, Michigan (Bahl and Johnson), Becton Dickinson and Co, Franklin Lakes, New Jersey (Alsbrooks and Hoerauf), and Bryn Mawr Hospital, Bryn Mawr, Pennsylvania (Zazyczny)
- Amit Bahl, MD, is a physician scientist with board certification in emergency medicine and subspeciality expertise in point-of-care ultrasound. He is the recipient of several foundation and industry grants for research and has authored numerous peer-reviewed manuscripts in high-impact medical journals. Dr Bahl is a passionate speaker who presents internationally on the complications of vascular access devices and strategies to improve patient outcomes
- Kim Alsbrooks has over 30 years of experience in the medical field. She started as a Radiologic Technologist then Registered Nurse, working on specialized hospital teams in Oncology and Vascular Access. She has worked at BARD/Becton, Dickinson, and Company, where she is now the Sr Director of Medical Affairs, for the past 20 years. Her work is mostly focused on vascular access evidence generation and research. Kim speaks across the US and internationally on vascular access topics
- Kelly Ann Zazyczny, BSN, RN, RT (R), VA-BC, is the director of nursing of the Psychiatric, Women, and Children's Division at Bryn Mawr Hospital, Vascular Access Nursing Services for the Main Line Health System. She has been a clinical leader for over 25 years, holding positions at Main Line Health, The Children's Hospital of Philadelphia, and Children's Healthcare of Atlanta. Her clinical focus has been on pediatrics, vascular access, radiology, and research. She has been named one of the Top Nurses in Nursing Management by Main Line Today for the last 3 years
- Steven Johnson, DO, is a board-certified emergency medicine physician and critical care fellow at the University of Southern California. He also conducts catheter-related research in his work as a research scientist at Beaumont Health. He developed a passion for improving peripheral venous access after witnessing firsthand how poor catheter performance affects patient outcomes and overall health
- Klaus Hoerauf, MD, PhD, currently serves as worldwide vice president of medical affairs, medication delivery solutions, at Becton, Dickinson, and Company. In this role, he leads Medical & Scientific Affairs and Health Economics and Outcomes Research departments. He has an MD and a Doctorate in Cardiology from the Medical University of Münster and has been appointed as associate professor of anesthesiology and intensive care medicine at the Medical University of Vienna, Austria. He is certified in anesthesiology and intensive care medicine, emergency medicine, and pain therapy
| |
Collapse
|
2
|
Mörgeli R, Schmidt K, Neumann T, Kruppa J, Föhring U, Hofmann P, Rosenberger P, Falk E, Boemke W, Spies C. A comparison of first-attempt cannulation success of peripheral venous catheter systems with and without wings and injection ports in surgical patients-a randomized trial. BMC Anesthesiol 2022; 22:88. [PMID: 35361115 PMCID: PMC8969381 DOI: 10.1186/s12871-022-01631-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Accepted: 03/21/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND A peripheral venous catheter (PVC) is the most widely used device for obtaining vascular access, allowing the administration of fluids and medication. Up to 25% of adult patients, and 50% of pediatric patients experience a first-attempt cannulation failure. In addition to patient and clinician characteristics, device features might affect the handling and success rates. The objective of the study was to compare the first-attempt cannulation success rate between PVCs with wings and a port access (Vasofix® Safety, B. Braun, abbreviated hereon in as VS) with those without (Introcan® Safety, B. Braun, abbreviated hereon in as IS) in an anesthesiological cohort. METHODS An open label, multi-center, randomized trial was performed. First-attempt cannulation success rates were examined, along with relevant patient, clinician, and device characteristics with univariate and multivariate analyses. Information on handling and adherence to use instructions was gathered, and available catheters were assessed for damage. RESULTS Two thousand three hundred four patients were included in the intention to treat analysis. First-attempt success rate was significantly higher with winged and ported catheters (VS) than with the non-winged, non-ported design (IS) (87.5% with VS vs. 78.2% with IS; PChi < .001). Operators rated the handling of VS as superior (rating of "good" or "very good: 86.1% VS vs. 20.8% IS, PChi < .001). Reinsertion of the needle into the catheter after partial withdrawal-prior or during the catheterization attempt-was associated with an increased risk of cannulation failure (7.909, CI 5.989-10.443, P < .001 and 23.023, CI 10.372-51.105, P < .001, respectively) and a twofold risk of catheter damage (OR 1.999, CI 1.347-2.967, P = .001). CONCLUSIONS First-attempt cannulation success of peripheral, ported, winged catheters was higher compared to non-ported, non-winged devices. The handling of the winged and ported design was better rated by the clinicians. Needle reinsertions are related to an increase in rates of catheter damage and cannulation failure. TRIAL REGISTRATION ClinicalTrials.gov, Identifier: NCT02213965 , Date: 12/08/2014.
Collapse
Affiliation(s)
- Rudolf Mörgeli
- Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charitépl. 1, 10117, Berlin, Germany
| | - Katrin Schmidt
- Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charitépl. 1, 10117, Berlin, Germany
| | - Tim Neumann
- Department of Anesthesiology and Operative Intensive Care Medicine (CBF), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany
| | - Jochen Kruppa
- Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charitépl. 1, 10117, Berlin, Germany
| | - Ulrich Föhring
- Department of Anesthesiology and Operative Intensive Care Medicine (CBF), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Berlin, Germany
| | - Pascal Hofmann
- Universitätsklinik Für Anästhesiologie Und Intensivmedizin Tübingen, Universitätsklinikum Tübingen, 72076, Tübingen, Germany
| | - Peter Rosenberger
- Universitätsklinik Für Anästhesiologie Und Intensivmedizin Tübingen, Universitätsklinikum Tübingen, 72076, Tübingen, Germany
| | - Elke Falk
- Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charitépl. 1, 10117, Berlin, Germany
| | - Willehad Boemke
- Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charitépl. 1, 10117, Berlin, Germany
| | - Claudia Spies
- Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charitépl. 1, 10117, Berlin, Germany.
| |
Collapse
|